HRA003748
Title:
Tumor microenvironment assessment-based signatures for predicting response to immunotherapy in non-small cell lung cancer
Release date:
2024-06-07
Description:
Immune checkpoint blockades (ICBs) have significantly altered the treatment paradigm for patients with non-small cell lung cancer (NSCLC) without driver mutations, but not all patients experience durable benefits. Predictive biomarkers are needed to identify patients who may benefit from ICBs. We obtained tumor specimens from NSCLC patients before anti-PD-1 inhibitor treatment and performed transcriptomic analysis to generate tumor microenvironment characteristics. Based on tumor microenvironment data, we sought to establish biomarker to predict immunotherapy efficacy for NSCLC.
Data Accessibility:   
Controlled access Request Data
BioProject:
Study type:
Disease Study
Disease name:
lung cancer
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
DAC name:
NFHZLK_DAC
Contact person:
Liao Wangjun
Email:
liaowj@smu.edu.cn
Description:
RNA-seq data from the Department of Oncology, Nanfang Hospital.
Individuals & samples
Submitter:   Liao Wangjun / liaowj@smu.edu.cn
Organization:   Nanfang Hospital, Southern Medical University
Submission date:   2022-04-28
Requests:   1